ZA836933B - 1-phenyl-2(h,3h)-indolone psycho-therapeutic agents - Google Patents

1-phenyl-2(h,3h)-indolone psycho-therapeutic agents

Info

Publication number
ZA836933B
ZA836933B ZA836933A ZA836933A ZA836933B ZA 836933 B ZA836933 B ZA 836933B ZA 836933 A ZA836933 A ZA 836933A ZA 836933 A ZA836933 A ZA 836933A ZA 836933 B ZA836933 B ZA 836933B
Authority
ZA
South Africa
Prior art keywords
phenyl
indolone
psycho
indolones
treatment
Prior art date
Application number
ZA836933A
Other languages
English (en)
Inventor
Harry Ralph Howard
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA836933B publication Critical patent/ZA836933B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA836933A 1982-09-20 1983-09-19 1-phenyl-2(h,3h)-indolone psycho-therapeutic agents ZA836933B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/420,544 US4476307A (en) 1982-09-20 1982-09-20 Heteroylidene indolone compounds

Publications (1)

Publication Number Publication Date
ZA836933B true ZA836933B (en) 1985-05-29

Family

ID=23666904

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA836933A ZA836933B (en) 1982-09-20 1983-09-19 1-phenyl-2(h,3h)-indolone psycho-therapeutic agents

Country Status (24)

Country Link
US (1) US4476307A (https=)
EP (1) EP0104860B1 (https=)
JP (1) JPS5976058A (https=)
KR (1) KR860001270B1 (https=)
AT (1) ATE25972T1 (https=)
AU (1) AU543115B2 (https=)
CA (1) CA1194871A (https=)
DD (1) DD213211A5 (https=)
DE (1) DE3370325D1 (https=)
DK (1) DK157010C (https=)
ES (3) ES8503328A1 (https=)
FI (1) FI77446C (https=)
GR (1) GR79732B (https=)
HU (1) HU189747B (https=)
IE (1) IE55923B1 (https=)
IL (1) IL69758A (https=)
NO (1) NO161557C (https=)
NZ (1) NZ205638A (https=)
PH (1) PH18297A (https=)
PL (3) PL141876B1 (https=)
PT (1) PT77360B (https=)
SU (1) SU1272983A3 (https=)
YU (4) YU189283A (https=)
ZA (1) ZA836933B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879391A (en) * 1982-09-20 1989-11-07 Pfizer Inc. 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
WO1990008146A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
US5078756A (en) * 1990-01-12 1992-01-07 Major Thomas O Apparatus and method for purification and recovery of refrigerant
US5158969A (en) * 1991-08-21 1992-10-27 Neurosearch A/S Indole derivatives as potassium channel blockers
US5760250A (en) * 1991-11-05 1998-06-02 Zeneca Limited Process for the preparation of 3-(α-methoxy)methylenebenzofuranones and intermediates therefor
DE19949209A1 (de) * 1999-10-13 2001-04-19 Boehringer Ingelheim Pharma In 5-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
AU2002341881B2 (en) * 2001-09-27 2008-05-08 Allergan, Inc. 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
MXPA04009365A (es) * 2002-03-27 2005-01-25 Lundbeck & Co As H Metodo para la manufactura de sertindol.
FR2847811B1 (fr) * 2002-11-29 2005-01-07 Oreal Composition filtrante contenant au moins un derive du dibenzoylmethane et au moins un derive de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one;procede de photostabilisation
FR2847813A1 (fr) * 2002-11-29 2004-06-04 Oreal Compositions cosmetiques photoprotectrices contenant des derives de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one et utilisations
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
CN102099036B (zh) 2008-06-03 2015-05-27 英特芒尼公司 用于治疗炎性疾患和纤维化疾患的化合物和方法
US8222430B2 (en) 2008-12-19 2012-07-17 Nippon Soda Co., Ltd. 1-heterodiene derivative and harmful organism control agent
KR101376443B1 (ko) 2009-11-12 2014-03-19 닛뽕소다 가부시키가이샤 1-헤테로디엔 유도체 및 유해 생물 방제제
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3506683A (en) * 1963-10-07 1970-04-14 Upjohn Co 3-(2-pyrrolidinylidene)-3h-indoles
GB1237008A (en) * 1968-12-18 1971-06-30 Pfizer Ltd Novel indoline derivatives
US3723457A (en) * 1969-09-30 1973-03-27 Eisai Co Ltd Indoline-2-one derivatives and preparation thereof
GB1374414A (en) * 1972-06-12 1974-11-20 Sterling Drug Inc 1-acyl-3-amino-alkyl-indoles and their preparation
DE2557342A1 (de) * 1975-12-19 1977-06-30 Hoechst Ag Basisch substituierte indolderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ES8505950A1 (es) 1985-06-01
DK157010B (da) 1989-10-30
PL141609B1 (en) 1987-08-31
NO161557B (no) 1989-05-22
PH18297A (en) 1985-05-24
DE3370325D1 (en) 1987-04-23
DK425383D0 (da) 1983-09-19
PL250769A1 (en) 1985-07-02
KR840006239A (ko) 1984-11-22
NO161557C (no) 1989-08-30
JPS6241711B2 (https=) 1987-09-04
PT77360A (en) 1983-10-01
YU169286A (en) 1987-10-31
NO833367L (no) 1984-03-21
IE55923B1 (en) 1991-02-27
EP0104860A1 (en) 1984-04-04
DK425383A (da) 1984-05-03
EP0104860B1 (en) 1987-03-18
DK157010C (da) 1990-03-26
PL141876B1 (en) 1987-09-30
PL243826A1 (en) 1985-04-24
CA1194871A (en) 1985-10-08
YU169186A (en) 1987-10-31
AU543115B2 (en) 1985-04-04
DD213211A5 (de) 1984-09-05
SU1272983A3 (ru) 1986-11-23
FI77446B (fi) 1988-11-30
YU189283A (en) 1987-10-31
ES531907A0 (es) 1985-06-01
PL250768A1 (en) 1985-07-02
FI833335A7 (fi) 1984-03-21
GR79732B (https=) 1984-10-31
ES8505951A1 (es) 1985-06-01
JPS5976058A (ja) 1984-04-28
PL141370B1 (en) 1987-07-31
FI77446C (fi) 1989-03-10
HU189747B (en) 1986-07-28
ES525737A0 (es) 1985-02-16
AU1925283A (en) 1984-03-29
NZ205638A (en) 1986-12-05
IE832193L (en) 1984-03-20
ATE25972T1 (de) 1987-04-15
ES8503328A1 (es) 1985-02-16
FI833335A0 (fi) 1983-09-19
YU169386A (en) 1987-10-31
PT77360B (en) 1986-05-19
IL69758A0 (en) 1983-12-30
ES531908A0 (es) 1985-06-01
US4476307A (en) 1984-10-09
KR860001270B1 (ko) 1986-09-04
IL69758A (en) 1986-12-31

Similar Documents

Publication Publication Date Title
DE3370325D1 (en) 1-phenyl-2(1h,3h)-indolone psycho-therapeutic agents
DE69111791D1 (de) Zwischenübertragungsverfahren und rolle für die übertragung.
ATE40365T1 (de) 3-acylaminomethylimidazo (1,2-a> pyridine, dessen herstellung und therapeutische anwendung.
DE69111077D1 (de) Chinazolinderivate um die antitumorwirkung zu verbessern.
GB9503601D0 (en) Method of treatment and method of manufacture of medicament
OA09478A (fr) "Utilisation de la N-myristoyl-(S)-phénylalaine pour l'obtention de médicaments destinés au traitement des maladies faisant intervenir la myristoylation".
GR3035682T3 (en) Non-glycosylated fgf-4 and compositions containing the same.
DE3889974D1 (de) Pyrazol-Derivate und diese enthaltende Behandlungsmittel für cerebrovaskulare Krankheiten.
DE3567211D1 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
ATE20519T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und chloroquin.
WO1994006345A3 (en) Immunosorbent for use in the diagnosis of neuro-psychological disorders, and use thereof
FR2698000B1 (fr) Table d'hydromassage.
DK0833638T3 (da) Anvendelse af imidazo[1,5-a]quinoloner som neuroprotektive midler
ES510231A0 (es) "mejoras introducidas en el objeto de la patente principal n 499.085, por maquina desrabadora de aceitunas".
OA09211A (fr) "Composition antifongique adaptée aux traitements des mycoses superficielles".
IT1263076B (it) Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.
KR960009710U (ko) 고환의 기능을 고려해 개선한 남성용 팬티